Sino Biological (301047.SZ) launched its 4RISE platform, offering high-throughput validation for AI-designed molecules, featuring 3-hour expression times and access to over 11,000 target proteins.
The company announces its 4RISE wet-lab validation service for AI-designed molecules, citing ~3-hour cell-free expression, over 11,000 ready-made target proteins and collaborations with more than 50 AI companies. This is a service and capability launch without revenue, order values or guidance figures, so it supports the growth narrative but contains no hard financial fact likely to move the share price materially.
Sino Biological has introduced 4RISE, an integrated wet-lab solution designed to validate AI-generated protein candidates. The platform leverages cell-free synthesis to achieve expression in approximately 3 hours and utilizes a library of over 11,000 ready-made target proteins to accelerate drug discovery cycles. The company currently supports these workflows through existing collaborations with more than 50 AI-focused firms.
No. The announcement describes capabilities such as expression in about 3 hours, over 11,000 ready-made target proteins and cooperation with more than 50 AI companies, but states no revenue, orders or guidance.